129 related articles for article (PubMed ID: 36605530)
1. Identification of a transcription factor‑cyclin family genes network in lung adenocarcinoma through bioinformatics analysis and validation through RT‑qPCR.
Yang X; Zhou Y; Ge H; Tian Z; Li P; Zhao X
Exp Ther Med; 2023 Jan; 25(1):63. PubMed ID: 36605530
[TBL] [Abstract][Full Text] [Related]
2. Identifying and Validating Potential Biomarkers of Early Stage Lung Adenocarcinoma Diagnosis and Prognosis.
Chen Y; Jin L; Jiang Z; Liu S; Feng W
Front Oncol; 2021; 11():644426. PubMed ID: 33937050
[TBL] [Abstract][Full Text] [Related]
3. Identification and Integrate Analysis of Key Biomarkers for Diagnosis and Prognosis of Non-Small Cell Lung Cancer Based on Bioinformatics Analysis.
Gong K; Zhou H; Liu H; Xie T; Luo Y; Guo H; Chen J; Tan Z; Yang Y; Xie L
Technol Cancer Res Treat; 2021; 20():15330338211060202. PubMed ID: 34825846
[No Abstract] [Full Text] [Related]
4. An integrated analysis of prognostic and immune infiltrates for hub genes as potential survival indicators in patients with lung adenocarcinoma.
Xu Z; Wang S; Ren Z; Gao X; Xu L; Zhang S; Ren B
World J Surg Oncol; 2022 Mar; 20(1):99. PubMed ID: 35354488
[TBL] [Abstract][Full Text] [Related]
5. Identification of HMMR as a prognostic biomarker for patients with lung adenocarcinoma
Li Z; Fei H; Lei S; Hao F; Yang L; Li W; Zhang L; Fei R
PeerJ; 2021; 9():e12624. PubMed ID: 35036134
[TBL] [Abstract][Full Text] [Related]
6. [TRIP13 Enhances Radioresistance of Lung Adenocarcinoma Cells
through the Homologous Recombination Pathway].
Ge S; Gu R; Yang X; Xu C; Wang S; Zhu G
Zhongguo Fei Ai Za Zhi; 2024 Jan; 27(1):1-12. PubMed ID: 38296621
[TBL] [Abstract][Full Text] [Related]
7. Comprehensive Analysis of Candidate Diagnostic and Prognostic Biomarkers Associated with Lung Adenocarcinoma.
Li J; Liu X; Cui Z; Han G
Med Sci Monit; 2020 Jun; 26():e922070. PubMed ID: 32578582
[TBL] [Abstract][Full Text] [Related]
8. Identification of key genes and biological pathways in lung adenocarcinoma via bioinformatics analysis.
Wang Y; Zhou Z; Chen L; Li Y; Zhou Z; Chu X
Mol Cell Biochem; 2021 Feb; 476(2):931-939. PubMed ID: 33130972
[TBL] [Abstract][Full Text] [Related]
9. PKMYT1 as a Potential Target to Improve the Radiosensitivity of Lung Adenocarcinoma.
Long HP; Liu JQ; Yu YY; Qiao Q; Li G
Front Genet; 2020; 11():376. PubMed ID: 32411179
[TBL] [Abstract][Full Text] [Related]
10. Screening of Key Prognosis Genes of Lung Adenocarcinoma Based on Expression Analysis on TCGA Database.
Shen Y; Tang X; Zhou X; Yi Y; Qiu Y; Xu J; Tian X
J Oncol; 2022; 2022():4435092. PubMed ID: 36600965
[TBL] [Abstract][Full Text] [Related]
11. Transcriptomic analysis reveals the potential biological mechanism of AIS and lung adenocarcinoma.
Qin RX; Yang Y; Chen JF; Huang LJ; Xu W; Qin QC; Liang XJ; Lai XY; Huang XY; Xie MS; Chen L
Front Neurol; 2023; 14():1119160. PubMed ID: 37265472
[TBL] [Abstract][Full Text] [Related]
12. Identification of crucial genes associated with lung adenocarcinoma by bioinformatic analysis.
Dai JJ; Zhou WB; Wang B
Medicine (Baltimore); 2020 Oct; 99(44):e23052. PubMed ID: 33126397
[TBL] [Abstract][Full Text] [Related]
13. Key genes involved with prognosis were identified in lung adenocarcinoma by integrated bioinformatics analysis.
Song H; Wu J; Liu W; Cai K; Xie Z; Liu Y; Huang J; Gan S; Xiong Y; Sun Y
Heliyon; 2023 Jun; 9(6):e16789. PubMed ID: 37313154
[TBL] [Abstract][Full Text] [Related]
14. Identification of key genes and evaluation of clinical outcomes in lung squamous cell carcinoma using integrated bioinformatics analysis.
Shi Y; Li Y; Yan C; Su H; Ying K
Oncol Lett; 2019 Dec; 18(6):5859-5870. PubMed ID: 31788059
[TBL] [Abstract][Full Text] [Related]
15. Bioinformatical Analysis of Gene Expression Omnibus Database Associates TAF7/CCNB1, TAF7/CCNA2, and GTF2E2/CDC20 Pathways with Glioblastoma Development and Prognosis.
Yang L; Zeng W; Sun H; Huang F; Yang C; Cai X; Lu Y; Zeng J; Yang K
World Neurosurg; 2020 Jun; 138():e492-e514. PubMed ID: 32147549
[TBL] [Abstract][Full Text] [Related]
16. FOXM1 and CENPF are associated with a poor prognosis through promoting proliferation and migration in lung adenocarcinoma.
Li P; Ma G; Cui Z; Zhang S; Su Q; Cai Z
Oncol Lett; 2023 Dec; 26(6):518. PubMed ID: 37920441
[TBL] [Abstract][Full Text] [Related]
17. High Expression of
Deng H; Huang Y; Wang L; Chen M
Biomed Res Int; 2020; 2020():2071593. PubMed ID: 33134373
[TBL] [Abstract][Full Text] [Related]
18. SKA1/2/3 serves as a biomarker for poor prognosis in human lung adenocarcinoma.
Chen C; Guo Q; Song Y; Xu G; Liu L
Transl Lung Cancer Res; 2020 Apr; 9(2):218-231. PubMed ID: 32420061
[TBL] [Abstract][Full Text] [Related]
19. Identification of Prognostic Signature and Gliclazide as Candidate Drugs in Lung Adenocarcinoma.
Cheng Y; Hou K; Wang Y; Chen Y; Zheng X; Qi J; Yang B; Tang S; Han X; Shi D; Wang X; Liu Y; Hu X; Che X
Front Oncol; 2021; 11():665276. PubMed ID: 34249701
[TBL] [Abstract][Full Text] [Related]
20. miR-335-5p Regulates Cell Cycle and Metastasis in Lung Adenocarcinoma by Targeting CCNB2.
Wang X; Xiao H; Wu D; Zhang D; Zhang Z
Onco Targets Ther; 2020; 13():6255-6263. PubMed ID: 32636645
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
